cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. 1985

A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio

Thirty-four patients with measurable metastatic gastric adenocarcinoma refractory to prior chemotherapy were treated with cis-platinum 100 mg/m2 in a 6-hr infusion at 3-week intervals. Thirty-one patients were evaluable for response. There were three complete and three partial responses. Median duration of response was 4 months. Toxicity consisted mainly of nausea and vomiting and was severe in 12 patients. One patient had a severe but reversible renal failure. These results confirm other data reported in the literature. Cis-platinum has activity in gastric adenocarcinoma and should now be further investigated in first-line chemotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
January 1990, European journal of cancer (Oxford, England : 1990),
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
January 1992, Cancer chemotherapy and pharmacology,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
January 1991, European journal of gynaecological oncology,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
June 1998, British journal of cancer,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
September 1985, European journal of cancer & clinical oncology,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
January 2007, Anticancer research,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
December 1983, Journal of surgical oncology,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
August 1993, Annals of oncology : official journal of the European Society for Medical Oncology,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
January 1985, Oncology,
A J Lacave, and J Wils, and E Diaz-Rubio, and M Clavel, and A Planting, and H Bleiberg, and N Duez, and O Dalesio
January 1979, Cancer treatment reports,
Copied contents to your clipboard!